Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07557030 · ClinicalTrials.gov registry record · NA
Optimization for Toric Contact Lenses
A NA study, sponsored by CooperVision International Limited (CVIL).
- Not yet
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT07557030: Clinical Trial NA study, sponsored by CooperVision International Limited (CVIL).
NCT07557030 is a NA study that has not yet begun recruiting, run by CooperVision International Limited (CVIL). The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07557030, a NA study, has not yet begun recruiting, sponsored by CooperVision International Limited (CVIL).
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The aim of this study is to evaluate the agreement between subjective and objective toric lens prescriptions.
Primary Outcome
Proportion of eyes in which the optimized toric lens cylinder axis determined by the subjective method agrees with that determined by the objective method within ±10 degrees (measured at a single time point).
Interventions
- DEVICE Lens 1 ( stenfilcon A )
- DEVICE Lens 2 ( comfilcon A )
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2026-05 |
| Est. Completion | 2026-08 |
| Phase | NA |
What is known before NCT07557030 opens enrollment
NCT07557030 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Lens 1 ( stenfilcon A ) is the first listed.
NCT07557030 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07557030 about?
NCT07557030 is a clinical study titled "Optimization for Toric Contact Lenses". The aim of this study is to evaluate the agreement between subjective and objective toric lens prescriptions.
What is the current status of trial NCT07557030?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2026-05. Estimated completion is 2026-08.
What interventions are being tested in trial NCT07557030?
The interventions under investigation include: Lens 1 ( stenfilcon A ) (DEVICE), Lens 2 ( comfilcon A ) (DEVICE).
Who is sponsoring clinical trial NCT07557030?
This trial is sponsored by CooperVision International Limited (CVIL), which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07557030's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia